This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Minoryx Therapeutics S.l.. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: Marc Revés Vilaplana: Innovator in Pharmaceutical Compounds
Introduction
Marc Revés Vilaplana is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceutical compounds, particularly in the development of heteroaryl compounds aimed at treating lysosomal storage diseases.
Latest Patents
Marc Revés Vilaplana holds 2 patents. His latest patents include innovative compounds that are directed towards the treatment and prevention of lysosomal storage diseases, such as Gaucher's disease. These compounds are characterized by their specific formulas and methods of preparation, as well as their pharmaceutical compositions.
Career Highlights
Marc is currently associated with Minoryx Therapeutics S.L., where he continues to advance his research and development efforts. His work focuses on creating effective treatments for diseases that are classified as synucleinopathies.
Collaborations
He collaborates with esteemed colleagues, including Ana Maria García Collazo and Xavier Barril Alonso, to further enhance the impact of his research in the pharmaceutical industry.
Conclusion
Marc Revés Vilaplana is a dedicated inventor whose work in pharmaceutical compounds is paving the way for new treatments for serious diseases. His contributions are vital to the ongoing advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile